HCPCS Level IIdrugActive
J9038
Inj axatilimab-csfr 0.1 mg
BETOS: O1D
Effective: 2025-07-01
Description
Injection, axatilimab-csfr, 0.1 mg
Medicare Part B Drug Pricing
Average Sales Price (ASP) data for Q1 2026
Drug Name
Niktimvo
Manufacturer
Incyte Corporation
HCPCS Dosage
0.1 MG
Billing Units
500.0000
3
NDC Products
asp
Pricing Source
Medicare Part B drugs are reimbursed at ASP + 6%. Pricing updates quarterly based on manufacturer-reported data.